bullish
Takeda Sells Japan OTC Business to Blackstone; Last of Its Non-Core Asset Sales to Raise US$10bn
252 Views25 Aug 2020 13:36
Takeda announced on Monday (24th August 2020) that it has entered into an agreement to sell its domestic consumer health business (known as Takeda...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Takeda Sells Japan OTC Business to Blackstone; Last of Its Non-Core Asset Sales to Raise US$10bn25 Aug 2020
- Reliance: Acquisition of Stake in Netmeds to Strengthen JioMart’s Position in the E-Commerce Space21 Aug 2020
- Taisho Pharma Seems the Best Suitor for Takeda’s Japan OTC Business24 Jun 2020
- Takeda Pharma Divests Yet Another Non-Core Asset to Pay-Off Debt and Focus on Core Areas29 Apr 2020
x